Zhengxi Biotech announced that it has received $3,100,000 in a round of funding from Zhejiang Orient Gene Biotech Co., Ltd. on June 8, 2022.
Zhejiang Orient Gene Biotech Co.,Ltd
Equities
688298
CNE100003RM8
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.11 CNY | -0.32% | -3.07% | -21.39% |
Jun. 12 | US FDA Grants Emergency Use Authorization to Orient Gene Biotech's COVID-19 Test Kit | MT |
May. 16 | Orient Gene Biotech's US Unit Gets FDA Clearance for Fentanyl Detectors | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.39% | 785M | |
-3.07% | 8.27B | |
+7.95% | 5.81B | |
+29.16% | 5.58B | |
-16.16% | 3.85B | |
+10.30% | 2.71B | |
-64.76% | 2.56B | |
-9.60% | 2.42B | |
+21.68% | 2.13B | |
-9.05% | 1.77B |
- Stock Market
- Equities
- 688298 Stock
- News Zhejiang Orient Gene Biotech Co.,Ltd
- ZXBio, Inc. announced that it has received $3.1 million in funding from Zhejiang Orient Gene Biotech Co., Ltd.